A. Tagliamonte

2.4k total citations
65 papers, 1.9k citations indexed

About

A. Tagliamonte is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, A. Tagliamonte has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in A. Tagliamonte's work include Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (20 papers) and Tryptophan and brain disorders (9 papers). A. Tagliamonte is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (28 papers), Neuroscience and Neuropharmacology Research (20 papers) and Tryptophan and brain disorders (9 papers). A. Tagliamonte collaborates with scholars based in Italy, United States and Czechia. A. Tagliamonte's co-authors include Gian Luigi Gessa, Maria Graziella De Montis, P. Tagliamonte, G. L. Gessa, Maria C. Olianas, Carla Gambarana, L Vargiu, Giovanni Biggio, Jorge Pérez-Cruet and Giovanni Corsini and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

A. Tagliamonte

65 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Tagliamonte Italy 28 1.1k 536 307 259 207 65 1.9k
L Vargiu Italy 17 1.5k 1.4× 788 1.5× 396 1.3× 255 1.0× 264 1.3× 36 2.4k
E. Mogilnicka Poland 27 1.0k 0.9× 583 1.1× 192 0.6× 191 0.7× 267 1.3× 72 1.8k
Edith D. Hendley United States 28 911 0.8× 610 1.1× 364 1.2× 354 1.4× 248 1.2× 65 2.1k
David G. Grahame‐Smith United Kingdom 23 1.3k 1.1× 779 1.5× 230 0.7× 279 1.1× 171 0.8× 40 2.1k
N. Suzan Nadi United States 25 1.2k 1.1× 660 1.2× 190 0.6× 231 0.9× 248 1.2× 37 1.9k
Teresa J. Tolliver United States 19 909 0.8× 499 0.9× 137 0.4× 218 0.8× 179 0.9× 25 1.6k
F. Javoy France 23 1.6k 1.4× 728 1.4× 330 1.1× 167 0.6× 269 1.3× 38 2.3k
L Baran Poland 19 930 0.8× 548 1.0× 260 0.8× 225 0.9× 74 0.4× 45 1.4k
F. Lejeune France 16 1.1k 1.0× 666 1.2× 140 0.5× 224 0.9× 267 1.3× 39 1.8k
Zehava Gottesfeld United States 24 1.1k 0.9× 542 1.0× 291 0.9× 130 0.5× 259 1.3× 70 1.9k

Countries citing papers authored by A. Tagliamonte

Since Specialization
Citations

This map shows the geographic impact of A. Tagliamonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tagliamonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tagliamonte more than expected).

Fields of papers citing papers by A. Tagliamonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Tagliamonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tagliamonte. The network helps show where A. Tagliamonte may publish in the future.

Co-authorship network of co-authors of A. Tagliamonte

This figure shows the co-authorship network connecting the top 25 collaborators of A. Tagliamonte. A scholar is included among the top collaborators of A. Tagliamonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Tagliamonte. A. Tagliamonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Scheggi, Simona, et al.. (2004). Dopamine and cyclic AMP‐regulated phosphoprotein‐32 phosphorylation pattern in cocaine and morphine‐sensitized rats. Journal of Neurochemistry. 90(4). 792–799. 29 indexed citations
4.
Masi, Flavio, Simona Scheggi, Simona Mangiavacchi, et al.. (2000). Acquisition of an appetitive behavior reverses the effects of long-term treatment with lithium in rats. Neuroscience. 100(4). 805–810. 10 indexed citations
5.
Montis, Maria Graziella De, et al.. (1993). REDUCED [<sup>3</sup>H]SCH 23390 BINDING AND DA-SENSITIVE ADENYLYL CYCLASE IN THE LIMBIC SYSTEM OF ETHANOL-PREFERRING RATS. Alcohol and Alcoholism. 28(4). 397–400. 29 indexed citations
6.
Montis, Maria Graziella De, et al.. (1992). NMDA receptor inhibition prevents tolerance to cocaine. Pharmacology Biochemistry and Behavior. 42(1). 179–182. 42 indexed citations
7.
Montis, Maria Graziella De, et al.. (1990). Receptors modulation by chronic imipramine treatment. European Journal of Pharmacology. 183(5). 2055–2055. 1 indexed citations
8.
Montis, Maria Graziella De, Paola Devoto, Pierluigi Saba, & A. Tagliamonte. (1990). Effect of calcium antagonists on [3H]dopamine uptake. Pharmacological Research. 22. 46–47. 2 indexed citations
9.
Montis, Maria Graziella De, et al.. (1989). Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390. Journal of Neuroscience Research. 24(2). 286–292. 4 indexed citations
10.
Devoto, Paola, et al.. (1986). Opiate k receptors agonists do not inhibit adenylate cyclase activity. UNICA IRIS Institutional Research Information System (University of Cagliari). 1 indexed citations
11.
Olianas, Maria C., et al.. (1976). Synergistic potentiation of halopoderidol‐induced catalepsy by γ‐ butyrolactone. Journal of Neurochemistry. 27(3). 821–823. 5 indexed citations
12.
Tagliamonte, A., Maria Graziella De Montis, Maria C. Olianas, et al.. (1975). SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE. Journal of Neurochemistry. 24(4). 707–710. 81 indexed citations
13.
Gessa, Gian Luigi & A. Tagliamonte. (1975). Effect of methadone and dextromoramide on dopamine metabolism: Comparison with haloperidol and amphetamine. Neuropharmacology. 14(12). 913–920. 27 indexed citations
14.
Gessa, G. L. & A. Tagliamonte. (1974). Possible role of free serum tryptophan in the control of brain tryptophan level and serotonin synthesis.. PubMed. 11(0). 119–31. 43 indexed citations
15.
Tagliamonte, A., Walter Fratta, M. Del Fiacco, & Gian Luigi Gessa. (1974). Possible stimulatory role of brain dopamine in the copulatory behavior of male rats. Pharmacology Biochemistry and Behavior. 2(2). 257–260. 82 indexed citations
16.
Gessa, G L, et al.. (1974). Norepinephrine and dopamine concentrations in the cerebral cortex of man, monkeys and other mammals. Cellular and Molecular Life Sciences. 30(11). 1295–1296. 16 indexed citations
17.
Cramer, Hinrich, A. Tagliamonte, P. Tagliamonte, Jorge Pérez-Cruet, & Gian Luigi Gessa. (1973). Stimulation of brain serotonin turnover by paradoxical sleep deprivation in intact and hypophysectomized rats. Brain Research. 54. 372–375. 21 indexed citations
18.
Tagliamonte, A., et al.. (1972). BLOCKADE BY APOMORPHINE OF HALOPERIDOL-INDUCED DYSKINESIA IN SCHIZOPHRENIC PATIENTS. The Lancet. 300(7784). 981–982. 12 indexed citations
19.
Spano, PierFranco, A. Tagliamonte, P. Tagliamonte, & G. L. Gessa. (1971). STIMULATION OF BRAIN DOPAMINE SYNTHESIS BY GAMMA‐HYDROXYBUTYRATE. Journal of Neurochemistry. 18(10). 1831–1836. 54 indexed citations
20.
Gessa, Gian Luigi, B Loddo, G Brotzu, et al.. (1966). Selective inhibition of poliovirus growth by d-penicillamine in vitro. Virology. 30(4). 618–622. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026